Cottonwood Technology Fund invests in Reyedar (prev. Reperio Medtech) to Revolutionize Degenerative Disease Screening by combining Eye Tracking and Deep Learning
News Articles | Press Releases
  • Homepage
  • 5
  • Posts
  • 5
  • News Articles
  • 5
  • Cottonwood Technology Fund invests in Reyedar (prev. Reperio Medtech) to Revolutionize Degenerative Disease Screening by combining Eye Tracking and Deep Learning

Cottonwood Technology Fund invests in Reyedar (previous Reperio Medtech) to Revolutionize Degenerative Disease Screening by combining Eye Tracking and Deep Learning

5 July 2023 – Reyedar, a deeptech startup developing a proprietary medical technology platform for early detection of age-related degenerative diseases, announced today that it

secured a € 3 million investment to further advance its ground-breaking solution. Eye tracking technology combined with deep learning provides a unique window to the brain and to people’s health situations in which many age-related diseases can be detected. The funding round is led by Cottonwood Technology Fund, a leading venture capital firm that invests in early-stage deeptech companies. The round was joined by NOM, Pupil Labs, Uneti Ventures, and existing investor Blue Sparrows MedTech Fund.

As the aging population grows rapidly, the number of people with degenerative diseases such as Glaucoma, Parkinson’s, and Multiple Sclerosis increases. Screening methods for these diseases are often invasive, unreliable, and time-consuming, leading to pressure on the healthcare system. Reyedar’s technology solves this problem by detecting early symptoms within minutes in a non-invasive way. Combining deep learning with eye tracking sensors on a user-friendly device, the company improves treatment outcomes and decreases healthcare costs.

Reyedar, previously known as Reperio Medtech, is a spin-off company of the Ophthalmology Department of the University Medical Center Groningen in the Netherlands.

“This investment is a huge opportunity to accelerate the development and commercialization of our technology. Everyone in our team is really thankful and thrilled to close this investment. It will accelerate the development and commercialization of our technology,” said Dr. Alessandro Grillini, Founder & CEO of Reyedar. “With this funding we will grow our team, launch our first product in the eye care market, expand our product offering and ultimately improve the lives of millions of people affected by age-related degenerative diseases.”

“It is very exciting to lead this investment in Reyedar and support the development of this ground-breaking technology,” said Patrick Claessen, Partner of Cottonwood Technology Fund. “Reyedar has an experienced team and developed an impressive technology platform that translates eye movement to actionable medical insights. The company has the potential to make a huge positive impact on human lives by healthier aging for millions of people.”

“We are delighted to participate in this funding round for Reyedar,” said Annemieke Wouterse, Senior Investment Manager at NOM. “The company’s innovative technology offers early detection of multiple degenerative diseases using the eyes as a window into one’s health. This technology significantly reduces waiting lists in the health sector, and we look forward to working with the team to bring their technology to market.”

About Reyedar
Reyedar is a medical technology company on a mission to improve access to early diagnosis of life-impairing degenerative diseases. By using eye tracking sensors and artificial intelligence, the company creates medical devices for diagnosing visual impairments, neurological diseases, and cognitive disorders. This unique hardwaresoftware combination called SONDA (Standardized Oculomotor and Neuro-ophthalmic Disorders Assessment) allows for extremely fast, objective, and user-friendly testing. To learn more about Reyedar, visit https://www.reyedar.com/

About Cottonwood Technology Fund
Cottonwood Technology Fund is a venture capital firm that invests in early-stage technology companies. The firm has a focus on deep-tech startups in the areas of cleantech, medtech, robotics, photonics, nanotechnology, advanced materials and sensor technology. Cottonwood Technology Fund has offices in the United States and the Netherlands. The investment in Reyedar is managed by the Cottonwood Dutch Seed Fund vehicle, which includes financial Dutch government support from RVO.
Current and prior investments include Skorpios Technologies, Sarcos Robotics (NASDAQ: STRC), Exagen (NASDAQ: XGN), BayoTech, Sencure, Infinitum Electric, Flexiramics, FibeRio (acquired by Clarcor), xF Technologies, TriLumina (acquired by Lumentum), SoundEnergy, OPNT, BioFlyte, Circular Genomics and SmartNanotubes Technologies. Visit https://www.cottonwood.vc for more information.

 

Sencure
We are gladly having Cottonwood Technology Fund on board as lead investor. They are very supportive on aligning strategy and execution. The first year they ...
...Read More
Jurryt Vellinga, CEO
Sencure BV
We are gladly having Cottonwood Technology Fund on board as lead investor. They are very supportive on aligning strategy and execution. The first year they brought in already 8 corporates as potential customer. We are surprised every time about their extensive entrepreneurial mindset, business experience and global network of Cottonwood. They have been very smart people and 24/7 supportive.
Sencure
Jurryt Vellinga, CEO
Sencure BV
BayoTech
We would not exist, or certainly not in New Mexico, if it were not for Cottonwood. Until Cottonwood got involved we struggled to get attention ...
...Read More
Justin Eisenbach, President and CEO
Bayotech Corp
We would not exist, or certainly not in New Mexico, if it were not for Cottonwood. Until Cottonwood got involved we struggled to get attention from other capital providers. Cottonwood has been a real catalyst, beyond their money, to upgrading our management team, opening doors to potential strategic investors and customers and focusing on our market entry strategy. Cottonwood has been a great partner in driving our success in every area. I truly believe they wake up every day looking for ways and ideas that can support our success.
BayoTech
Justin Eisenbach, President and CEO
Bayotech Corp
Skorpios Technologies, Inc.
Cottonwood began working with me a year before they closed their first fund. Even though they weren’t initially in a position to invest they...
...Read More
Steve Krasulick, President & CEO
Skorpios Technologies
Cottonwood began working with me a year before they closed their first fund. Even though they weren’t initially in a position to invest they still opened doors to potential investors and customers, and assisted with the fund raising strategy and execution plan. Once their fund was closed they took an aggressive lead role in pulling together our first round and helping us launch the company. Now after having raised almost $150M they continue to support our growth, provide valuable advice and open doors to additional resources as we need them. We have been fortunate to have Cottonwood as a partner in building our company.
Skorpios Technologies, Inc.
Steve Krasulick, President & CEO
Skorpios Technologies